Perspective Therapeutics (CATX) Selling, General & Administrative (2010 - 2026)
Perspective Therapeutics (CATX) recorded Selling, General & Administrative of $7.8 million in Q2 2026, up 1.1% from $7.71 million a year earlier and up 11.6% from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a TTM basis, Perspective Therapeutics' Selling, General & Administrative came in at $30.33 million as of Jun 30, 2026, down 1.4% year-over-year; for FY2025, it came in at $30.23 million, up 13.6% from FY2024.
- Annual Selling, General & Administrative has increased for three straight years, with a five-year compound annual growth rate of 45.9% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $26.61 million in FY2024 (+26.3%), $21.06 million in FY2023 (+181.4%), $7.49 million in FY2022 and $4.69 million in FY2021 (+2.6%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q1 2025.
- On a year-over-year basis, Selling, General & Administrative rose in five of the last six quarters, with growth averaging 31.0%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 66.9% in Q4 2024, against a decline of 11.8% in Q1 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Perspective Therapeutics | 311.46 Mn | 311.46 Mn | - | 7.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.80 Mn |
| Mar 31, 2026 | 6.99 Mn |
| Jun 30, 2025 | 7.71 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 8.25 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 4.94 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 6.66 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.58 Mn |
| Dec 31, 2021 | 1.62 Mn |
| Sep 30, 2021 | 1.84 Mn |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 1.13 Mn |
API Access
Perspective Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();